Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alvita C Y, Chan"'
Autor:
Erin, Jou, Myung, Woo, Ashish, Subedi, David, Chao, Edith, Chow, Oleg, Gligich, Alvita C Y, Chan, Diwakar, Mohan, Uriel R, Felsen, Henny H, Billett, Radha, Raghupathy
Publikováno v:
Blood Coagulation & Fibrinolysis. 33:473-475
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb5342a8c8d8ad45134eb9fc3e395996
https://doi.org/10.1097/mbc.0000000000001136
https://doi.org/10.1097/mbc.0000000000001136
Autor:
Erin Jou, Edwin P. Hui, Diwakar Mohan, Henny H. Billett, Oleg Gligich, Anthony T.C. Chan, Radha Raghupathy, Sabarish Ayyappan, Uriel R. Felsen, Alvita C. Y. Chan
Publikováno v:
Hematological Oncology. 35:64-68
The significance of HIV associated paraproteins and their risk of progression to hematological malignancies remains unclear. We compared the development of hematological malignancies among HIV+ (n = 266) and HIV- (n = 537) patients with monoclonal ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::170e39831850fe26c9a153fdbd6acb13
https://doi.org/10.1002/hon.2247
https://doi.org/10.1002/hon.2247
Autor:
Erin, Jou, Oleg, Gligich, Alvita C Y, Chan, Diwakar, Mohan, Uriel R, Felsen, Sabarish, Ayyappan, Henny H, Billett, Edwin P, Hui, Anthony T, Chan, Radha, Raghupathy
Publikováno v:
Hematological oncology. 35(1)
The significance of HIV associated paraproteins and their risk of progression to hematological malignancies remains unclear. We compared the development of hematological malignancies among HIV+ (n = 266) and HIV- (n = 537) patients with monoclonal ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a87a9ae4e2e8bac080ba4c6d57afced
https://pubmed.ncbi.nlm.nih.gov/26205037
https://pubmed.ncbi.nlm.nih.gov/26205037
Autor:
Radha Raghupathy, Sabarish Ayyappan, Henny H. Billett, Diwakar Mohan, Oleg Gligich, Uriel R. Felsen, Alvita C. Y. Chan, Erin Jou, Anthony T.C. Chan, Edwin P. Hui
Publikováno v:
Cancer Research. 75:5594-5594
BACKGROUND: Paraproteinemias occur in 1 to 3% of people over the age of 50 and progress to hematological malignancies (HM) at the rate of about 1% per year. In HIV+ patients a higher incidence of paraproteinemia has been reported however the rate of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b53fece6edf801c5fca3b132e13653e
https://doi.org/10.1158/1538-7445.am2015-5594
https://doi.org/10.1158/1538-7445.am2015-5594